Most Active Biotech Investors in Paris 2026

8 firms writing Biotech checks in Paris, led by Andera Partners, Kreos Capital, Life Extension Ventures — ranked by verified deal count with the companies.

Biotech in Paris accounts for 4 tracked companies with verified cap-table data, 4 of which disclose round sizes totalling $333M. The median disclosed raise is $55M, and the largest is Abivax at $204M, ahead of EG 427 ($55M) and Coave Therapeutics ($39M).

The names that recur most often on these biotech cap tables are Truffle Capital (1 company), Andera Partners (1 company), Bpifrance Life Sciences Venture (1 company), SCI Ventures (1 company), Cohesion Bureau (1 company), David Lamond (1 company). By latest disclosed round, the market skews IPO (1), Series B (1), Seed (1).

Best funded Biotech in Paris companies

  1. Abivax — $204M (latest: IPO)
  2. EG 427 — $55M
  3. Coave Therapeutics — $39M (latest: Series B)
  4. Bioptimus — $35M (latest: Seed)

Sector × city funding reports (20)

All research · Investor directory · Company funding database · Fundraising library